Libertyville, IL, United States of America

Chunqiu Lai

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 7.3

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2006-2020

Loading Chart...
Loading Chart...
14 patents (USPTO):

Title: The Innovative Contributions of Chunqiu Lai

Introduction

Chunqiu Lai is a prominent inventor based in Libertyville, IL, known for his significant contributions to the field of pharmaceuticals. With a total of 14 patents to his name, Lai has made remarkable strides in developing compounds that target critical health issues, particularly cancer.

Latest Patents

Among his latest patents are the Macrocyclic MCL-1 inhibitors and methods of use. This patent provides compounds of formula (I) that are useful as agents in the treatment of various diseases and conditions, including cancer. The disclosure also includes pharmaceutical compositions comprising these compounds. Another notable patent is for Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors. This patent outlines compounds of Formula (IIa) that may also be used as agents in the treatment of diseases, including cancer, along with their pharmaceutical compositions.

Career Highlights

Chunqiu Lai has worked with several reputable companies throughout his career, including AbbVie Inc. and Karo Bio AB. His work in these organizations has contributed to the advancement of innovative treatments in the pharmaceutical industry.

Collaborations

Lai has collaborated with notable professionals in his field, including Thomas Dale Penning and Keith W. Woods. These collaborations have further enhanced his research and development efforts.

Conclusion

Chunqiu Lai's innovative work and numerous patents reflect his dedication to improving healthcare through pharmaceutical advancements. His contributions are vital in the ongoing fight against cancer and other diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…